A new trading day began on Monday, with Twist Bioscience Corp (NASDAQ: TWST) stock price down -6.76% from the previous day of trading, before settling in for the closing price of $38.17. TWST’s price has ranged from $27.12 to $60.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 1.70% over the last five years. Meanwhile, its annual earnings per share averaged 40.64%. With a float of $56.69 million, this company’s outstanding shares have now reached $59.86 million.
The firm has a total of 923 workers. Let’s measure their productivity. In terms of profitability, gross margin is 46.7%, operating margin of -57.86%, and the pretax margin is -55.03%.
Twist Bioscience Corp (TWST) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 5.39%, while institutional ownership is 110.05%. The most recent insider transaction that took place on Jul 02 ’25, was worth 4,524. In this transaction See Remarks of this company sold 125 shares at a rate of $36.19, taking the stock ownership to the 104,612 shares. Before that another transaction happened on Jul 02 ’25, when Company’s President and COO sold 209 for $36.19, making the entire transaction worth $7,564. This insider now owns 240,574 shares in total.
Twist Bioscience Corp (TWST) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 40.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.99% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Here are Twist Bioscience Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.37 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Analysing the last 5-days average volume posted by the [Twist Bioscience Corp, TWST], we can find that recorded value of 0.82 million was lower than the volume posted last year of 1.1 million. As of the previous 9 days, the stock’s Stochastic %D was 63.47%.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 35.47%, which indicates a significant decrease from 46.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.28% in the past 14 days, which was lower than the 68.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.76, while its 200-day Moving Average is $41.75. Now, the first resistance to watch is $37.25. This is followed by the second major resistance level at $38.91. The third major resistance level sits at $39.82. If the price goes on to break the first support level at $34.68, it is likely to go to the next support level at $33.78. Should the price break the second support level, the third support level stands at $32.12.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
With a market capitalization of 2.13 billion, the company has a total of 59,916K Shares Outstanding. Currently, annual sales are 312,970 K while annual income is -208,730 K. The company’s previous quarter sales were 92,790 K while its latest quarter income was -39,330 K.
